首页|期刊导航|老年心脏病学杂志(英文版)|A clinical nomogram for predicting major adverse cardiovascular and cerebrovascular events in elderly Chinese patients with acute coronary syndrome undergoing percutaneous coronary interve-ntion:development and validation in a real-world cohort
A clinical nomogram for predicting major adverse cardiovascular and cerebrovascular events in elderly Chinese patients with acute coronary syndrome undergoing percutaneous coronary interve-ntion:development and validation in a real-world cohort
Jing-Jing XU Jing-Yu WANG Xue-Yan ZHAO Lei SONG Jin-Qing YUAN Yin ZHANG Qin-Xue LI De-Shan YUAN Pei-Zhi WANG Yi-Chun HAO Pei ZHU Ying SONG Yi YAO Lin JIANG
老年心脏病学杂志(英文版)2025,Vol.22Issue(12):953-963,11.
老年心脏病学杂志(英文版)2025,Vol.22Issue(12):953-963,11.DOI:10.26599/1671-5411.2025.12.003
A clinical nomogram for predicting major adverse cardiovascular and cerebrovascular events in elderly Chinese patients with acute coronary syndrome undergoing percutaneous coronary interve-ntion:development and validation in a real-world cohort
A clinical nomogram for predicting major adverse cardiovascular and cerebrovascular events in elderly Chinese patients with acute coronary syndrome undergoing percutaneous coronary interve-ntion:development and validation in a real-world cohort
摘要
引用本文复制引用
Jing-Jing XU,Jing-Yu WANG,Xue-Yan ZHAO,Lei SONG,Jin-Qing YUAN,Yin ZHANG,Qin-Xue LI,De-Shan YUAN,Pei-Zhi WANG,Yi-Chun HAO,Pei ZHU,Ying SONG,Yi YAO,Lin JIANG..A clinical nomogram for predicting major adverse cardiovascular and cerebrovascular events in elderly Chinese patients with acute coronary syndrome undergoing percutaneous coronary interve-ntion:development and validation in a real-world cohort[J].老年心脏病学杂志(英文版),2025,22(12):953-963,11.基金项目
This study was supported by the National High Level Hospital Clinical Research Funding(2025-GSP-QN-31&2022-GSP-QN-1),the Young Talent Program of the Acade-mician Fund(YS-2022-002),and the Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences(CIFMS)(2023-I2M-1-002).All authors had no co-nflicts of interest to disclose. (2025-GSP-QN-31&2022-GSP-QN-1)